ArticleActa neurologica Belgica2026
Clinical and genetic characteristics of pediatric patients with vanishing white matter disease: a retrospective single-center study.
Article in Acta neurologica Belgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveVanishing White Matter Disease (VWM) is a rare autosomal recessive leukoencephalopathy caused by pathogenic variants in the EIF2B gene complex. This study aimed to describe the clinical, radiological, and genetic characteristics of four genetically confirmed pediatric patients with VWM who were followed up at our center. MATERIALS AND
methodsMedical records of four patients followed up at the Department of Pediatrics, Faculty of Medicine, Firat University, Elazığ, Türkiye were retrospectively reviewed. Demographic data, clinical presentation, magnetic resonance imaging (MRI) findings, and genetic analysis results were evaluated for all patients. Genetic testing was performed using whole-exome sequencing (WES).
resultsThree patients were male and one female. Parental consanguinity was present in all families (second-degree cousins). The mean age at diagnosis was 2.0 ± 1.35 years. The most common presentations were vomiting and infection-related neurological deterioration. Epilepsy was present in three patients. Brain MRI showed diffuse hypomyelination, frontoparietal periventricular white matter involvement, and cystic degeneration. Pathogenic variants were identified in the EIF2B5 and EIF2B4 genes in three and one patient, respectively. Variable ages of onset and disease courses were observed in patients carrying different EIF2B variants. Two patients died early, and two remained bedridden.
conclusionVWM is a rare childhood leukoencephalopathy characterized by stress-triggered neurological deterioration and clinical variability. Accurate diagnosis requires the combined evaluation of clinical findings, MRI features, and genetic results. VWM should be considered in children with consanguinity and neurological deterioration following an infection.
Indexed as
Identifiers
42260212What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.